
Blaine Labs Revitaderm and Tridergel wound care gel recalled for bacterial contamination
Blaine Labs is recalling three lot numbers of Revitaderm and Tridergel wound care gel (1 oz. and 3 oz. bottles/tubes) because they may contain Lysinibacillus fusiformis, a bacterium found in the environment. The affected products were distributed to healthcare providers only, not sold in stores. No injuries have been reported so far.
From the FDA notice · Read the official notice ↗
What to do
- Check your inventory for the affected lot numbers: BL3608, BL3435, or BL3525
- Stop using the product immediately if you have any of these lot numbers
- Set aside any remaining product and contact Blaine Labs at the number provided to arrange return
- If you have wounds treated with this gel and develop signs of infection (redness, warmth, increased drainage, fever), contact your healthcare provider
Is yours affected?
Compare your label or packaging with the recalled product.
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Photos from the FDA
Details
- Illnesses reported
- None reported
In the FDA's words
Santa Fe Springs, California – April 07, 2026 – Blaine Labs, Inc. is voluntarily recalling three (3) lot numbers of Wound Care Gel products, 1 oz. & 3 oz. (0.1% Benzalkonium Chloride) to the consumer level due to microbial contamination.
The affected product has been found to contain Lysinibacillus fusiformis , an environmental organism.
Risk Statement
Read the full announcementShow less
This voluntary recall has been initiated as a precautionary measure due to the detection of microbial presence. The tested samples identified the presence of Lysinibacillus fusiformis . Lysinibacillus fusiformis is an environmental, spore-forming bacterium.
While it is generally considered to have low pathogenicity in healthy individuals, it can survive in adverse conditions and may act as an opportunistic organism. Patients with open wounds, compromised skin barriers, or weakened immune systems (e.g., elderly, diabetic, or immunocompromised individuals) may be at increased risk for infection, skin irritation, and / or delayed wound healing. In immunocompromised individuals, including those with poorly controlled diabetes, elderly individuals with immune senescence, and young children with an immature immune system, these infections may become severe and lead to life-threatening complications such as endocarditis or central system infection.
The product is used as a topical antiseptic for first aid to help prevent the risk of infection in minor cuts, scrapes, and burns and is packaged in a 1 oz. bottle and 3 oz. tube. The Revitaderm® Wound Care Gel can be identified by its purple trim and Tridergel™ Wound Care can be identified by its light blue trim. The 1 oz. bottle has two cap configurations, twist and longer pointy cap, and is secured with a shrink / body band. The bottle has the expiration date and lot number printed on the bottom portion of the bottle. The 3 oz. is a tube and contains the lot number and expiration date imprinted along the crimp at the top of the tube. Revitaderm® Wound Care Antiseptic Gel 1 oz. & 3 oz. and Tridergel™ Wound Care 1 oz. was distributed nationwide in the U.S to healthcare providers (doctor’s offices) they were not distributed for retail or internet sales.
Product Description: 1 oz. & 3 oz. Revitaderm® Wound Care Antiseptic Gel
Active Ingredient: Benzalkonium Chloride 0.1%
Lot Number/EXP Date/Packaging: BL3608, 07/01/28 Printed with Yellow ink on the bottom of the bottle (1 oz.), shorter twist cap.
Lot Number/EXP Date/Packaging: BL3435, 11/06/26 Printed with Black ink on the bottom of the bottle (1 oz.), long pointy cap
Lot Number/EXP Date/Packaging: BL3435, 11/06/26 Imprinted on the tube crimp (3 oz.)
Lot Number/EXP Date/Packaging: BL3525, 08/07/27 Printed with Black ink on the bottom of the bottle (1 oz.), long pointy cap
Lot Number/EXP Date/Packaging: BL3525, 08/07/27 Imprinted on the tube crimp (3 oz.)
Product Description: 1 oz. Tridergel™ Wound Care
Active Ingredient: Benzalkonium Chloride 0.1%
Lot Number/EXP Date/Packaging: BL3435, 11/06/26 Printed with Black ink on the bottom of the bottle (1 oz.), long pointy cap
To date, Blaine Labs has not received any reports of adverse events related to this recall.
What Customers Should Do
Customers & Healthcare providers should review their inventory for these affected lot number and discontinue use and / or distribution immediately. Immediately stop using the product. Segregate any remaining inventory of these lot numbers and please contact Blaine Labs, Inc to arrange for return.
Blaine Labs, Inc. is notifying its physician clinics by regular mail and by phone, as applicable, and is arranging for the return of undispensed 1 oz. and 3 oz. from lot numbers associated with this recall.
Consumers with questions regarding this recall can contact Blaine Labs, Inc directly by using the contact information listed below Monday through Friday 7:30AM to 4:00PM PST.
Contact Information:
You may also report adverse events or questions regarding this recall directly to Blaine Labs using the conta

